Leukaemia Care Logo
donate

Menu

08088 010 444

Our campaigns

We run campaigns throughout the year, and need you to get involved and help raise awareness.

Watch Wait Worry

Join our Watch Wait Worry campaign and help us to improve the support offered to patients on Watch and Wait.

LC50

Leukaemia Care is turning 50 this year. That’s 50 years of supporting patients and their families and providing them with the right information and advice.

Spot Leukaemia

September is Blood Cancer Awareness Month and we want to raise awareness of leukaemia with our Spot Leukaemia Campaign.

#myCNSmatters

We're saying thank you for the invaluable role that Clinical Nurse Specialists (CNS) have in a leukaemia patient's journey. We want CNSs to know that they matter to patients, to charities and to other healthcare professionals.

Living with Leukaemia

Living with Leukaemia is our annual patient survey that aims to reveal the experience of leukaemia patients from diagnosis through to treatment and living with or beyond blood cancer.

Leukaemia: I wasn’t born yesterday

As part of our report, we undertook a survey of over 1,300 leukaemia patients, to uncover the inequalities that are impacting on cancer survival and patient experience.

Leukaemia Myths

There are many myths about leukaemia. Get yourself clued up with the following guide

Read More

Take a Moment to Catch Up

View our latest news and blog articles

January 21st

Practicing mindfulness

Mindfulness is a psychological, self-help therapy that aims to improve your mental wellbeing. Read on to find out how you can make the most of mindfulness....

January 18th

Leukaemia Care Exercise Planner

To help get you off the mark we have created a printable exercise planner that allows you to map out your new workout targets and tick off your achievements. ...

January 18th

NICE approves venetoclax (VENCLYXTO) with rituximab for previously treated chronic lymphocytic leukaemia (CLL) patients

NHS England are to make the first targeted CLL chemotherapy-free combination treatment of a fixed duration available through routine commissioning to treat patients relapsing or failing a first treatment...